BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18416789)

  • 1. A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings.
    Baker JA; Lovell K; Harris N
    J Clin Nurs; 2008 May; 17(9):1122-31. PubMed ID: 18416789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings: a Delphi study.
    Baker JA; Lovell K; Harris N; Campbell M
    J Psychiatr Ment Health Nurs; 2007 Aug; 14(5):478-84. PubMed ID: 17635256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.
    Baker JA; Lovell K; Harris N
    Gen Hosp Psychiatry; 2007; 29(2):163-8. PubMed ID: 17336666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical decision-making for 'as needed' medications in mental health care.
    Usher K; Baker JA; Holmes C; Stocks B
    J Adv Nurs; 2009 May; 65(5):981-91. PubMed ID: 19291187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic PRN use among older people's inpatient mental health services.
    Baker JA; Keady J; Hardman P; Kay J; Jones L; Jolley D
    J Psychiatr Ment Health Nurs; 2010 Jun; 17(5):463-8. PubMed ID: 20584243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRN psychotropic medication and acute mental health nursing: reviewing the evidence.
    Molloy L; Field J; Beckett P; Holmes D
    J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):12-5. PubMed ID: 22801821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of evidence that the pro re nata regimen confers benefit: a review of the studies.
    Yoshida K; Suzuki T; Uchida H; Mimura M
    Int Clin Psychopharmacol; 2013 Sep; 28(5):228-37. PubMed ID: 23727905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of therapeutic interventions that accompany the administration of p.r.n. ('as required') psychotropic medication within acute mental health settings: a retrospective study.
    Curtis J; Baker JA; Reid AR
    Int J Ment Health Nurs; 2007 Oct; 16(5):318-26. PubMed ID: 17845551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of PRN medications and use of nonpharmacologic interventions in acute geropsychiatric settings: implications for practice.
    Lindsey PL; Buckwalter KC
    J Am Psychiatr Nurses Assoc; 2012; 18(2):82-90. PubMed ID: 22442015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro re nata use in a psychiatric intensive care unit.
    Mullen A; Drinkwater V
    Int J Ment Health Nurs; 2011 Dec; 20(6):409-17. PubMed ID: 21564456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding clinical decision making for PRN medication in mental health inpatient facilities.
    Usher K; Baker JA; Holmes CA
    J Psychiatr Ment Health Nurs; 2010 Aug; 17(6):558-64. PubMed ID: 20633084
    [No Abstract]   [Full Text] [Related]  

  • 16. Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2017 Aug; 26(4):402-408. PubMed ID: 27804222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wards features associated with high rates of medication refusal by patients: a large multi-centred survey.
    Baker JA; Bowers L; Owiti JA
    Gen Hosp Psychiatry; 2009; 31(1):80-9. PubMed ID: 19134514
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Saito E; Eng S; Grosso C; Ozinci Z; Van Meter A
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):250-260. PubMed ID: 31800304
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of non-pharmacological interventions attempted prior to pro re nata medication use.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2018 Feb; 27(1):296-302. PubMed ID: 28247580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Documentation of psychotropic pro re nata medication administration: An evaluation of electronic health records compared with paper charts and verbal reports.
    Martin K; Ham E; Hilton NZ
    J Clin Nurs; 2018 Aug; 27(15-16):3171-3178. PubMed ID: 29752835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.